This 130-kDa matriptase-HAI-2 complex may be similar to or identical to the complex formed in breast cancer cells, suggesting that the activation of other proteases along with the induction of matriptase zymogen activation may also occur in lymphoma cells. Here, SPINT2 is linked to breast carcinoma.